 |
 |

Disodium Etidronate Therapy for Dystrophic Cutaneous Calcification
Steven Fisher Rabens, MD;
John E. Bethune, MD
Arch Dermatol. 1975;111(3):357-361.
Abstract
A patient with extensive disabling dystrophic cutaneous calcification and possible scleroderma was treated with orally administered doses of a diphosphonate known as disodium etidronate. This course of therapy seemed to arrest and partially reverse the progression of the calcifying process. Some deep deposits were then seen to dissipate and be partially reabsorbed, while some small superficial deposits were extruded through the skin surface. New deposition or redeposition of calcific deposits were halted in most areas while the patient was under therapy. Clinically, pain was reduced, recurrent abscess formation ceased, and joint mobility was improved.
Author Affiliations
From the Department of Dermatology (Dr. Rabens) and Department of Medicine (Dr. Bethune), Los Angeles County/University of Southern California Medical Center, Los Angeles. Dr. Rabens is now in private practice in Encino, Calif.
Footnotes
Accepted for publication Aug 15, 1974.
Reprint requests to 5353 Balboa Blvd, Suite 101, Encino, CA 91316 (Dr. Rabens).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Large Subcutaneous Calcification in Systemic Lupus Erythematosus
Nomura et al.
Arch Dermatol 1990;126:1057-1059.
ABSTRACT
Extensive Calcinosis Cutis With Systemic Lupus Erythematosus
Rothe et al.
Arch Dermatol 1990;126:1060-1063.
ABSTRACT
Calcinosis Cutis Circumscripta: Treatment With an Intralesional Corticosteroid
Lee et al.
Arch Dermatol 1978;114:1080-1081.
ABSTRACT
|